[Evaluation of the therapeutic effect of duxil in chronic cerebral insufficiency. Analysis of 4636 patients at cerebrovascular risk].
Mémin
Y
Y
Hôpital de Sevran.
D000368:Aged; D015765:Almitrine; D001288:Attention; D002545:Brain Ischemia / Q000188:drug therapy*; D002908:Chronic Disease; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D002534:Hypoxia, Brain / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008568:Memory; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D012307:Risk Factors; D015016:Yohimbine / Q000627:therapeutic use*
D004338:Drug Combinations; D010879:Piperazines; D015016:Yohimbine; C037558:almitrine, raubasine drug combination; D015765:Almitrine
Evaluation de l'activité thérapeutique de duxil dans l'insuffisance cérébrale chronique. Analyse chez 4,636 malades a risque cérébro-vasculaire.